 |
|
Fexofenadine Hydrochloride
|
|
Rofecoxib
|
Cafferic acid phenethyl ester (CAPE)
|
|
Donepezil
|
1-Benzyl-4-formylpiperidine
|
5,6-Dimethoxy-1-indanone
|
3,4-Dihydroxybenzaldehyde
|
2-Aminopyrimidine
|
2-Chloro( or Bromo) pyrimidine
|
2-Hydroxypyrimidine Hydrochloride
|
|
 |
|
|
|
| |
|
|
CERTIFICATE OF ANALYSIS
Product: Celecoxib
|
Report Date: 2004-03-24
|
Batch No.: 040324
|
Manufacture Date: 2004-03-20
|
Batch Size: 150 kg
|
Package: 25 Kg/Drum
|
Subject
|
Enterprise Standard
|
Result
|
Appearance
|
White or almost white crystalline powder
|
White crystalline powder
|
Melting Point
|
160 ℃~ 165 ℃
|
161 ℃~ 162.5 ℃
|
Water
|
≤ 0.5%
|
0.15%
|
Related Substance
|
≤ 0.5%(single,max)
|
0.26%
|
≤ 1%(total)
|
0.35%
|
Content
|
≤ 99.0%
|
99.65%
|
Conclusion: Up To Enterprise Standard
|
Director: Wenmin Pan Inspector: Lingping Li Reviewer: Wenmin Pan
|
|
|
|
|
|
|
Copyright(C)2005,Zhejiang Excel Pharmaceutical Co., Ltd. .
Supported by ChemNet ChinaChemNet GoldTrust |
|
